Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Exxon Mobil | 5.82% | $82.90M | $630.06B | 38.70% | 74 Outperform | |
| Altria Group | 4.94% | $70.48M | $111.20B | 15.09% | 64 Neutral | |
| AbbVie | 4.60% | $65.51M | $406.87B | 7.38% | 66 Neutral | |
| Philip Morris | 4.16% | $59.31M | $264.60B | 12.61% | 61 Neutral | |
| Merck & Company | 3.93% | $56.00M | $286.28B | 22.33% | 80 Outperform | |
| Chevron | 3.87% | $55.22M | $379.00B | 21.49% | 71 Outperform | |
| AT&T | 3.67% | $52.31M | $200.50B | 5.60% | 71 Outperform | |
| PepsiCo | 3.43% | $48.95M | $217.88B | 3.23% | 78 Outperform | |
| Verizon | 3.03% | $43.14M | $215.61B | 10.98% | 81 Outperform | |
| Bristol-Myers Squibb | 2.49% | $35.43M | $122.78B | -1.31% | 78 Outperform |